Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry.
Morin-Dewaele M, Bartier S, Berry F, Brillet R, López-Molina DS, Nguyễn CT, Maille P, Sereno K, Nevers Q, Softic L, Vaugeois JM, Louis B, Bequignon E, Bruscella P, Coste A, Pawlotsky JM, Jamain S, Ahmed-Belkacem A. Morin-Dewaele M, et al. Among authors: coste a. Sci Rep. 2022 Dec 6;12(1):21053. doi: 10.1038/s41598-022-25399-5. Sci Rep. 2022. PMID: 36473907 Free PMC article.
Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells.
Majidipur A, Morin-Dewaele M, Gaspar Lopes J, Berry F, Fouchet J, Bartier S, Dufros Duval A, Soyeux P, Huet E, Louis B, Coste A, Béquignon É, Saldana C, Le Corvoisier P, Destouches D, Pawlotsky JM, de la Taille A, Vacherot F, Bruscella P, Firlej V. Majidipur A, et al. Among authors: coste a. Int J Mol Sci. 2023 Feb 7;24(4):3288. doi: 10.3390/ijms24043288. Int J Mol Sci. 2023. PMID: 36834705 Free PMC article.
[Unusual dysphagia].
Simondet N, Cailleaux C, Coste A. Simondet N, et al. Among authors: coste a. Rev Med Interne. 2023 Jan;44(1):40-41. doi: 10.1016/j.revmed.2022.11.003. Epub 2022 Nov 17. Rev Med Interne. 2023. PMID: 36404225 French. No abstract available.
Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology.
Seys SF, Hellings PW, Alobid I, Backer V, Bequignon E, von Buchwald C, Cavaliere C, Coste A, Deneyer L, Diamant Z, Eckl-Dorna J, Fokkens WJ, Gane S, Gevaert P, Holbaek-Haase C, Holzmeister C, Hopkins C, Hox V, Huart C, Jankowski R, Jorissen M, Kjeldsen A, Knipps L, Lange B, van der Lans R, Laulajainen-Hongisto A, Larsen K, Liu DT, Lund V, Mariën G, Masieri S, Mortuaire G, Mullol J, Reitsma S, Rombaux P, Schneider S, Steinsvik A, Tomazic PV, Toppila-Salmi SK, Van Gerven L, Van Zele T, Virkkula P, Wagenmann M, Bachert C. Seys SF, et al. Among authors: coste a. J Allergy Clin Immunol Pract. 2023 Feb;11(2):431-438.e2. doi: 10.1016/j.jaip.2022.09.043. Epub 2022 Oct 19. J Allergy Clin Immunol Pract. 2023. PMID: 36272718 Review.
Responders to biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: a multicentric observational real-life study.
Mortuaire G, Béquignon E, Daveau C, Papon JF, Lecanu JP, Favier V, de Gabory L, Vandersteen C, Castillo L, Saroul N, Vérillaud B, Carsuzaa F, Rumeau C, Jankowski R, Michel J, de Bonnecaze G, Escabasse V, Coste A, Lefèvre G, Malard O. Mortuaire G, et al. Among authors: coste a. Rhinology. 2024 Dec 11. doi: 10.4193/Rhin24.284. Online ahead of print. Rhinology. 2024. PMID: 39660730
519 results